Phagocytosis and killing by alveolar macrophages from humans, rabbits, rats, and hamsters were compared in vitro. In the absence of serum opsonins, human alveolar macrophages could phagocytize Staphylococcus aureus Cowan I (protein A positive), but not S. aureus EMS (protein A negative) or Pseudomonas aeruginosa MN. In contrast, rabbit, rat, and hamster alveolar macrophages did not phagocytize S. aureus Cowan I or other nonopsonized bacteria. Human alveolar macrophages, but not other species, stained positively with fluorescein isothiocyanate-conjugated protein A. When opsonized bacteria were studied, phagocytosis by human, rabbit, and hamster alveolar macrophages was found to be mediated by both Fc and C3 receptors. However, only Fc receptor-mediated phagocytosis of bacteria was demonstrated for rat alveolar macrophages. Differences were also found in the kinetics of bacterial killing by alveolar macrophages from different species. Human and rabbit alveolar macrophages rapidly killed opsonized S. aureus Cowan I. However, bacterial killing by hamster alveolar macrophages proceeded at a slower rate, and rat alveolar macrophages completely failed to kill S. aureus. These significant differences in the function of alveolar macrophages from four different species emphasize the need to document the appropriateness of animal models before using them to predict the biological activities of human alveolar macrophages. Alveolar macrophages (AM) constitute an important defense against inhaled microorganisms (4-6, 17). Knowledge regarding the phagocytic and bactericidal mechanisms of AM has been derived largely from studies with animal AM. The validity of extrapolating results from these studies to the functions of human AM has received little attention and needs to be assessed.
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Alveolar macrophages (AM) constitute an important defense against inhaled microorganisms (4) (5) (6) 17) . Knowledge regarding the phagocytic and bactericidal mechanisms of AM has been derived largely from studies with animal AM. The validity of extrapolating results from these studies to the functions of human AM has received little attention and needs to be assessed.
Our recent finding that, in contrast to rabbit AM (13) , human AM can phagocytize certain bacterial isolates in the absence of opsonins (8a) has prompted this comparative study of the phagocytic and killing functions of AM from humans, rabbits, rats, and hamsters. The results indicate that AM from these species differ in their abilities to recognize, ingest, and subsequently kill bacteria. 15.5 Ci/mmol; New England Nuclear Corp., Boston, Mass.) to Mueller-Hinton broth, as previously described (15, 19) . Radioactively labeled bacteria were grown, washed, and counted as described above.
Isolation of AM. After informed consent, human AM were obtained from normal donors (smokers and nonsmokers) by subsegmental saline lavage of the lingula of the left lung or the middle lobe of the right lung, as previously described (9 Opsonins and preopsonization of bacteria. Human blood was obtained by venipuncture and allowed to clot, and the serum was recovered by centrifugation, pooled, and frozen at -70°C. Rabbit, rat, and hamster sera obtained by cardiac puncture were similarly prepared. Just before use, pooled human, rabbit, rat, and hamster sera were thawed and diluted to the desired concentration with GHBSS. Heat-inactivated serum was obtained by heating serum in a 56°C water bath for 30 min.
For phagocytosis and killing studies, 0.1 ml of bacteria at 5 x 108/ml were preopsonized in polypropylene vials (Bio-vials; Beckman Instruments, Inc., Chicago, Ill.) with 0.9 ml of opsonin at the desired concentration for 15 min in a 37°C shaking incubator. At the end of incubation, bacteria were centrifuged at 2,000 x g for 15 min (4°C) and resuspended in 1 ml of GHBSS. Nonopsonized bacteria were prepared as described above, except GHBSS was used instead of serum.
Phagocytosis. Phagocytosis of bacteria by AM was assessed by measuring the uptake of radiolabeled bacteria with an assay described in detail previously (14) . Briefly, 0.1 ml of nonopsonized bacteria or bacteria opsonized in 10o autologous serum (5 x 107/ ml) were mixed with 0.1 ml of AM (5 x 106/ml) in duplicate polypropylene vials, and phagocytosis was allowed to proceed for 15 min in a 37°C shaking incubator. Phagocytosis was stopped by adding 3 ml of cold phosphate-buffered saline to one sample from each pair. This sample was then centrifuged at 160 x g for 5 min (4°C) and washed three more times to remove nonphagocyte-associated bacteria. The final pellet was suspended in scintillation liquid (Aquasol-2; New England Nuclear Corp.) and counted in a liquid scintillation counter (Beckman LS-250). To the other sample, scintillation liquid was added immediately after incubation, and the total number of radiolabeled bacteria added was counted (total counts per minute). The percent uptake was calculated as follows: percent uptake = (counts per minute of washed AM cell pellet [160 g]/total counts per minute) x 100.
Detection of surface immunoglobulins. Surface immunoglobulins on AM were detected by a modified method of a cell surface immunoglobulin assay described previously (3) . Briefly, 106 phagocytes in phosphate-buffered saline containing 2% fetal calf serum and 15 mg of sodium azide per 100 ml were mixed with fluorescein isothiocyanate-conjugated protein A (Pharmacia Fine Chemicals, Inc., Piscataway, N.J.) at 1:20 dilution and incubated at 4°C for 45 min. At the end of incubation, the cells were washed three times with the same phosphate-buffered saline (5 min at 1,200 rpm). The supernatant was then discarded, and a drop from the final pellets was placed on a clean slide and sealed with a cover slip. Slides were read on a Zeiss universal photomicroscope equipped with epifluorescence and phase-contrast systems.
Killing of S. aureus Cowan I by AM. Bacterial killing by AM was determined by a microtitration assay which quantitated the number of live S. aureus Cowan I cells after 0, 15, and 120 min of incubation with AM from each species. S. aureus Cowan I cells were preopsonized in 10% autologous serum as described above. For each incubation time, triplicate samples of 0.1 ml of opsonized bacteria (5 x 10'/ml) and 0.1 ml of phagocytes (5 x 106/ml) were incubated at 37°C in a shaking incubator (200 rpm). Bacterial killing was interrupted by adding 2.8 ml of cold, sterile distilled water to the samples. The sample was blended vigorously in a Vortex mixer, and a 1:200 dilution was made in 10 ml of sterile distilled water. Finally, 0.1 ml of this dilution was transferred to a U-shaped well of a 96-well tissue culture plate with cover (Flow Laboratories, Inc., Rockville, Md.) containing 0.1 ml of Mueller-Hinton broth in all wells. Serial twofold dilutions were performed. The microtiter plates were incubated at 37°C overnight, and the next day the number of live bacteria was calculated from the highest dilution that gave visible growth. The percentage of killing was determined for indicated time points as follows: percent killing = 100% -[(bacteria alive at indicated time/bacteria alive at 0 min) x 100].
RESULTS
Phagocytosis of nonopsonized bacteria by AM from different animal species. To determine whether AM from laboratory animals could ingest nonopsonized bacteria in a manner similar to that of human AM, phagocytosis of nonopsonized S. aureus Cowan I, S. aureus EMS (protein A-deficient mutant of Cowan I), and P.
aeruginosa MN (Fig. 1) was measured. After 15 min of incubation, there was a significant uptake of nonopsonized S. aureus Cowan I by human AM (82%). In sharp contrast, there was little uptake of this strain by AM from rabbits, rats, and hamsters (<15%). Thus, only human AM could recognize and ingest protein A-positive S. aureus Cowan I. There was no significant uptake of nonopsonized S. aureus EMS or of P. aeruginosa MN by AM from all four species (<10%).
In our previous studies with human AM, we have found that the mechanism of nonopsonic recognition of S. Phagocytosis of opsonized bacteria by AM from different animal species. We next determined whether uptake of opsonized bacteria by AM from humans, rabbits, rats, and hamsters was similar. S. aureus Cowan I, S. aureus EMS, and P. aeruginosa MN opsonized in 10% autologous serum were used to compare the opsonic recognition by AM from all four species (Fig. 2) . After opsonization, all strains were efficiently phagocytized by AM from humans and rabbits. In contrast, less efficient phagocytosis of all strains, especially P. aeruginosa MN, was observed with rat AM. Hamster AM, on the other hand, showed good uptake of S. aureus Cowan I but phagocytized S. aureus EMS and P. aeruginosa MN less well. Thus, there appears to be great variation among animal species in the ability of AM to recognize and phagocytize bacteria opsonized in autologous serum.
A single serum pool, 10%o pooled human serum (PHS), was also used in the comparison of the efficiency of all four species of AM to phagocytize opsonized S. aureus Cowan I, S. aureus EMS, and P. aeruginosa MN. AM from humans and rabbits efficiently phagocytized all three strains of bacteria (uptake by human and rabbit AM, .60 and .48%, respectively). Hamster AM were less efficient in phagocytizing the three strains of bacteria opsonized in 10% PHS. The percent uptake of S. aureus Cowan I, S. aureus EMS, and P. aeruginosa MN by hamster AM was 22, 22, and 26%, respectively. No significant uptake of S. aureus Cowan I, S. aureus EMS, or P. aeruginosa MN opsonized in 10% PHS was observed with rat AM (<8%). Thus, human, rabbit, rat, and hamster AM still differed in their efficiencies to phagocytize opsonized bacteria when PHS was substituted for autologous sera.
In addition, comparison of the above data with results obtained from experiments with 10% autologous serum (Fig. 2) indicates that PHS and rabbit serum can be used interchangeably to study phagocytosis of opsonized bacteria by rabbit AM. However, there appears to be species specificity for opsonins with hamster and rat AM. To avoid potential problems with species specificity for opsonins of the AM, autologous sera were used in the rest of this study.
Detection of receptors for heat-stable and heatlabile opsonins on AM from different animal species. Receptors on human, rabbit, rat, and hamster AM were studied by measuring the uptake of S. aureus EMS opsonized in heated serum. The uptake of S. aureus EMS opsonized in 10% heat-inactivated autologous serum was 75% for human AM, 34% for rabbit AM, 59% for rat AM, and 16% for hamster AM (Fig. 3) . This compared with <5% uptake of nonopsonized S. aureus EMS by AM from all four species (Fig.  1) . These data suggest that AM from all four EMS (protein A-) heat-labile opsonins that are involved in phagocytosis of P. aeruginosa. The lack of enhanced uptake of S. aureus EMS opsonized in fresh rat serum by rat AM (Fig. 3) and the failure of rat AM to phagocytize opsonized P. aeruginosa MN (Fig. 2) To investigate the receptors for heat-labile opsonins on the AM from humans, rabbits, rats, and hamsters, the uptake of S. aureus EMS opsonized in fresh autologous serum was examined. Enhanced uptake by rabbit and hamster AM was observed when S. aureus EMS was opsonized in fresh rabbit and hamster sera, suggesting that these AM possess membrane receptors for heat-labile opsonins. Enhanced uptake was not observed with human or rat AM when S. aureus EMS was opsonized in fresh serum. Indeed, depressed uptake of S. aureus EMS opsonized in fresh rat serum was observed with rat AM (Fig. 3) .
The equally efficient uptake by human AM of S. aureus EMS opsonized in fresh and in heatinactivated serum precluded any comment on the presence and function of AM receptors for heat-labile opsonins. To investigate further the presence of the receptors for heat-labile opsonins on human AM, P. aeruginosa MN opsonized by fresh PHS and heat-inactivated PHS was used (Fig. 4) . The importance of heat-labile serum factors in the phagocytosis of these bacteria was apparent at low concentrations of serum (1%). When P. aeruginosa MN was opsonized in heat-inactivated serum, the uptake at 5, 15, and 30 min was -11%. When fresh serum was used, the uptake at 5, 15, and 30 min was 38, 50, and 69%, respectively. This enhancement of uptake The inefficiency of rabbit, rat, and hamster AM in phagocytizing nonopsonized S. aureus and the lack of interaction between these phagocytes and fluorescein isothiocyanate-conjugated protein A suggest that AM from these species do not possess a mechanism for recognition of nonopsonized bacteria. Several previous investigations support our finding that rat AM are inefficient in phagocytizing S. aureus (10, 12) and that complement and antibodies are needed to promote efficient uptake of S. aureus and P. aeruginosa by rabbit AM (13) .
The absence of a mechanism for nonopsonic recognition may be due either to the absence of surface IgG on these AM or lack of anti-protein A reactivity of these immunoglobulins. It has been reported that human IgG3 lacks anti-protein A reactivity, whereas IgGi, IgG2, and IgG4 give a precipitin reaction with protein A (11).
Whether rabbit, rat, and hamster AM possess surface immunoglobulins that do not bind to protein A requires further studies.
The current investigation also demonstrates that, although human, rabbit, and hamster AM are similar in their abilities to phagocytize S.
aureus Cowan I opsonized in autologous serum, they differ in their capacities for killing S. aureus. In comparison with human and rabbit AM, the rate of killing of S. aureus Cowan I by hamster AM was slow in spite of normal phagocytosis. Inefficiency of the rat AM in killing opsonized S. aureus was probably a reflection of poor phagocytosis of this bacteria by rat AM and might be due, in part, to a rather unique need of these cells for alveolar lining material (10, 12) . In summary, the marked qualitative and quantitative differences in bacterial phagocytosis and killing by AM from humans, rabbits, rats, and hamsters underscore the importance of documenting the appropriateness of animal models before using them to predict the biological activities of human AM.
